• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声治疗阿扑吗啡输注的皮肤副作用:一项随机对照试验研究

Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study.

作者信息

Poltawski Leon, Edwards Hazel, Todd Amy, Watson Tim, Lees Andrew, James Cherry Ann

机构信息

Division of Physiotherapy, University of Hertfordshire, UK.

出版信息

Mov Disord. 2009 Jan 15;24(1):115-8. doi: 10.1002/mds.22316.

DOI:10.1002/mds.22316
PMID:19006068
Abstract

Apomorphine hydrochloride is a dopamine agonist used in the treatment of advanced Parkinson's disease. Its administration by subcutaneous infusions is associated with the development of nodules that may interfere with absorption of the drug. This pilot study assessed the effectiveness of ultrasound (US) in the treatment of these nodules. Twelve participants were randomly assigned to receive a course of real or sham US on an area judged unsuitable for infusion. Following treatment, no significant change was observed in measures of tissue hardness and tenderness. However, 5 of 6 participants receiving real US rated the treated area suitable for infusion compared with the 1 of 6 receiving sham US. Sonographic appearance improved in both groups, but more substantially in the real US group. Power calculations suggest a total sample size of 30 would be required to establish statistical significance. A full-scale study of the effectiveness of therapeutic US in the treatment of apomorphine nodules is warranted.

摘要

盐酸阿扑吗啡是一种用于治疗晚期帕金森病的多巴胺激动剂。通过皮下输注给药时,会出现结节,可能会影响药物吸收。这项初步研究评估了超声(US)治疗这些结节的有效性。12名参与者被随机分配到一个被判定不适合输注的区域接受真正的或假的超声治疗疗程。治疗后,组织硬度和压痛测量值未见显著变化。然而,接受真正超声治疗的6名参与者中有5名认为治疗区域适合输注,而接受假超声治疗的6名参与者中只有1名这样认为。两组的超声表现均有改善,但真正超声治疗组改善更明显。功效计算表明,需要30名的总样本量才能确定统计学意义。有必要对治疗性超声治疗阿扑吗啡结节的有效性进行全面研究。

相似文献

1
Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study.超声治疗阿扑吗啡输注的皮肤副作用:一项随机对照试验研究
Mov Disord. 2009 Jan 15;24(1):115-8. doi: 10.1002/mds.22316.
2
[Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications].[阿扑吗啡输注不良反应的治疗:皮下结节和神经精神并发症]
Rev Neurol. 2012;55 Suppl 1:S25-9.
3
Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease.阿扑吗啡诱发的帕金森病嗜酸性脂膜炎和嗜酸性粒细胞增多症。
Neurology. 2005 Jan 25;64(2):392-3. doi: 10.1212/01.WNL.0000149757.47854.6F.
4
[Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].[帕金森病患者皮下持续输注阿扑吗啡:81例患者的回顾性分析]
Rev Neurol (Paris). 2014 Mar;170(3):205-15. doi: 10.1016/j.neurol.2013.10.012. Epub 2014 Mar 1.
5
Apomorphine nodules in Parkinson's disease: best practice considerations.帕金森病中的阿扑吗啡小结:最佳实践考量
Br J Community Nurs. 2008 Oct;13(10):457-63. doi: 10.12968/bjcn.2008.13.10.31182.
6
An evaluation of subcutaneous apomorphine for the treatment of Parkinson's disease.阿朴吗啡皮下注射治疗帕金森病的评价。
Expert Opin Pharmacother. 2020 Oct;21(14):1659-1665. doi: 10.1080/14656566.2020.1787379. Epub 2020 Jul 8.
7
Apomorphine therapy in Parkinson's disease: a review.帕金森病的阿扑吗啡治疗:综述
Expert Opin Pharmacother. 2007 Nov;8(16):2799-809. doi: 10.1517/14656566.8.16.2799.
8
Use of apomorphine in Parkinson's disease.阿扑吗啡在帕金森病中的应用。
Neurol Sci. 2008 Dec;29 Suppl 5:S383-6. doi: 10.1007/s10072-008-1053-8.
9
Use of apomorphine in clinical practice.
Adv Neurol. 1999;80:529-33.
10
Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study.持续皮下注射阿扑吗啡治疗帕金森病运动波动:美国3期长期开放标签InfusON研究结果
J Parkinsons Dis. 2025 Mar;15(2):361-373. doi: 10.1177/1877718X241310727. Epub 2025 Jan 29.

引用本文的文献

1
Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review.阿朴吗啡持续皮下输注治疗帕金森病:系统评价。
Mov Disord Clin Pract. 2023 Jun 26;10(9):1253-1267. doi: 10.1002/mdc3.13810. eCollection 2023 Sep.
2
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease: the APOKADO study.家庭启动皮下阿朴吗啡输注治疗帕金森病患者的可行性和益处:APOKADO 研究。
J Neural Transm (Vienna). 2023 Nov;130(11):1463-1474. doi: 10.1007/s00702-023-02609-6. Epub 2023 Mar 2.
3
Intermittent Subcutaneous Injections of Apomorphine in Parkinson's Disease.
帕金森病中阿扑吗啡的间歇性皮下注射
Eurasian J Med. 2022 Dec;54(Suppl1):71-76. doi: 10.5152/eurasianjmed.2022.22134.
4
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's disease.阿朴吗啡制剂可能会影响帕金森病患者持续皮下注射阿朴吗啡引起的皮下并发症。
J Neurol. 2020 Nov;267(11):3411-3417. doi: 10.1007/s00415-020-10031-1. Epub 2020 Jul 1.
5
A Novel Method of Treating Apomorphine-Induced Subcutaneous Nodules.一种治疗阿扑吗啡诱导的皮下结节的新方法。
Mov Disord Clin Pract. 2019 Nov 17;7(1):83-85. doi: 10.1002/mdc3.12853. eCollection 2020 Jan.
6
Old Drugs, New Delivery Systems in Parkinson's Disease.帕金森病的老药新剂型
Drugs Aging. 2019 Sep;36(9):807-821. doi: 10.1007/s40266-019-00682-9.
7
The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues.皮肤与帕金森病:临床、诊断及治疗问题综述
Mov Disord Clin Pract. 2016 Sep 8;4(1):21-31. doi: 10.1002/mdc3.12425. eCollection 2017 Jan-Feb.
8
Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.阿扑吗啡在帕金森病中的应用的药理学研究进展:临床相关性。
Clin Drug Investig. 2018 Apr;38(4):287-312. doi: 10.1007/s40261-018-0619-3.